Travelers Vaccines Market Research Report | Forecast up to 2025

A vaccine is a chemical and biological preparation that helps fight a particular disease and boosts immunity. It contains an agent similar to a disease-causing organism, composed from the killed form of the microbe. The vaccine could be prophylactic or therapeutic. The term “vaccine” is derived from “variolae vaccinate” (cowpox). According to the World Health Organization, there are currently 25 licensed vaccines available to prevent infection. Their efficacy depends on the following parameters: the disease itself, the strain of the vaccine, schedule of vaccination, and the patient’s ethnicity & genetic predisposition. With rising globalization, the number of people travelling internationally is anticipated to increase, boosting the demand for travel products and propelling the market for travel vaccines substantially in the next couple of years. Various infectious diseases are prevalent in specific regions.

Depending on the type of composition, traveler vaccines are divided into two categories: mono and combination. Approvals by regulatory authorities specify the age group for receiving these vaccines. Combination vaccines are a rapidly expanding segment. They aid the prevention of infectious disease such as meningococcal diseases, Japanese encephalitis, and hepatitis A. Based on the type of use, these vaccines are split into the following varieties:

Attenuated vaccines
Inactive vaccines
Subunit vaccines
Toxoid vaccines
Conjugate vaccines
DNA vaccines
Recombinant vector vaccines

The low risk of serious side-effects in a fetus and educational & awareness initiatives by various government and non-profit organizations are factors driving the market. Growing preference for outsourcing of vaccines in developing and under-developing countries and the surge in outbound travel & vaccination coverage due to rising awareness drive the traveler’s vaccines market. However, strict regulatory pathways and high costs associated with new vaccine discoveries & development as well as the transportation, storage, and handling of existing vaccines restrict the market.

View Report –
http://www.transparencymarketresearch.com/travelers-vaccines-market.html

Geographically, the U.S. is likely to dominate the human vaccines market in North America. The combination vaccines segment is anticipated to expand rapidly, followed by attenuated and recombinant vaccines. In terms of product, the meningococcal vaccines segment is poised to develop at a high rate, while the combination vaccines segment presents major opportunities in North America. The European Medicines Agency has issued scientific guidelines on vaccines. Registration in the region could be done through the centralized, mutual recognition-based, or national procedures. These are responsible for the clinical evaluation of new vaccines & adjuvants in vaccines for human use and for providing a dossier structure & content for marketing authorization. In India, the Central Drugs and Standards Control Organization is the responsible body for vaccine regulation. It approves vaccines introduced in the country, grants permission to conduct clinical trials, and registers & controls the quality of imported vaccines. This group also provides various technical and policy-related factors about immunization programs in India and motivates the traveler’s vaccines market. The Saudi Ministry of Health (Saudi Food and Drug Authority) is the responsible body for regulation of vaccines in Saudi Arabia. The government of the country runs routine vaccination programs for flu, influenza, and other diseases, creating an opportunity for the traveler’s vaccines market.

Key players in the traveler’s vaccines market include GlaxoSmithKline, Merck, Pfizer, and Sanofi.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Travelers Vaccines Market during 2017- 2025
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25553

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.